These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10521265)

  • 1. Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation.
    Nicolaes GA; Villoutreix BO; Dahlbäck B
    Biochemistry; 1999 Oct; 38(41):13584-91. PubMed ID: 10521265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
    Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
    Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.
    Mellquist JL; Kasturi L; Spitalnik SL; Shakin-Eshleman SH
    Biochemistry; 1998 May; 37(19):6833-7. PubMed ID: 9578569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Bertina RM
    Thromb Haemost; 2003 Mar; 89(3):429-37. PubMed ID: 12624624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction.
    Corral-Rodríguez MÁ; Bock PE; Hernández-Carvajal E; Gutiérrez-Gallego R; Fuentes-Prior P
    Blood; 2011 Jun; 117(26):7164-73. PubMed ID: 21555742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assay to quantify the two plasma isoforms of factor V.
    Hoekema L; Rosing J; Tans G
    Thromb Haemost; 2000 Dec; 84(6):1066-71. PubMed ID: 11154115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchange of Ser-4 for Val, Leu or Asn in the sequon Asn-Ala-Ser does not prevent N-glycosylation of the cell surface glycoprotein from Halobacterium halobium.
    Zeitler R; Hochmuth E; Deutzmann R; Sumper M
    Glycobiology; 1998 Dec; 8(12):1157-64. PubMed ID: 9858637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin/choriogonadotropin receptor if Asn-173 is left intact.
    Liu X; Davis D; Segaloff DL
    J Biol Chem; 1993 Jan; 268(3):1513-6. PubMed ID: 8420926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
    van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
    Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
    Steen M; Villoutreix BO; Norstrøm EA; Yamazaki T; Dahlbäck B
    J Biol Chem; 2002 Dec; 277(51):50022-9. PubMed ID: 12384508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycosylation at non-canonical Asn-X-Cys sequence of an insect recombinant cathepsin B-like counter-defense protein.
    Chi YH; Koo YD; Dai SY; Ahn JE; Yun DJ; Lee SY; Zhu-Salzman K
    Comp Biochem Physiol B Biochem Mol Biol; 2010 May; 156(1):40-7. PubMed ID: 20139027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of N-linked core glycosylation: use of a site-directed mutagenesis approach to identify Asn-Xaa-Ser/Thr sequons that are poor oligosaccharide acceptors.
    Kasturi L; Chen H; Shakin-Eshleman SH
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):415-9. PubMed ID: 9163332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carbohydrate position on lysosomal transport of procathepsin L.
    Lingeman RG; Joy DS; Sherman MA; Kane SE
    Mol Biol Cell; 1998 May; 9(5):1135-47. PubMed ID: 9571245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple dimeric forms of human CD69 result from differential addition of N-glycans to typical (Asn-X-Ser/Thr) and atypical (Asn-X-cys) glycosylation motifs.
    Vance BA; Wu W; Ribaudo RK; Segal DM; Kearse KP
    J Biol Chem; 1997 Sep; 272(37):23117-22. PubMed ID: 9287313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.
    Gould WR; Silveira JR; Tracy PB
    J Biol Chem; 2004 Jan; 279(4):2383-93. PubMed ID: 14594814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex.
    Nicolaes GA; Villoutreix BO; Dahlbäck B
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):89-100. PubMed ID: 10691103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A database analysis of potential glycosylating Asn-X-Ser/Thr consensus sequences.
    Christlet TH; Biswas M; Veluraja K
    Acta Crystallogr D Biol Crystallogr; 1999 Aug; 55(Pt 8):1414-20. PubMed ID: 10417409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of N-glycosylation recognition sites on the biochemical properties of Aspergillus kawachii alpha-L-arabinofuranosidase 54.
    Koseki T; Miwa Y; Mese Y; Miyanaga A; Fushinobu S; Wakagi T; Shoun H; Matsuzawa H; Hashizume K
    Biochim Biophys Acta; 2006 Sep; 1760(9):1458-64. PubMed ID: 16784813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.